
Posted: September 2026
CJC-1295 (No DAC) and Ipamorelin are two distinct research peptides frequently supplied together as a combined stack. CJC-1295 is a growth-hormone-releasing hormone (GHRH) analog fragment, while Ipamorelin is a selective ghrelin-receptor (GHS-R) agonist — two different mechanisms of action studied together in growth-hormone axis research.
This overview is intended for educational and research information purposes only.
Laboratory interest in this combination centers on how two distinct receptor pathways may be studied together within growth-hormone axis research models.
Researchers frequently examine:
Because the two peptides act on different receptors, researchers often use this stack as a reference model for studying combined-pathway signaling.
Laboratory investigation frequently explores how GHRH-analog and ghrelin-receptor activity may interact within growth-hormone axis signaling models.
Research interest frequently includes:
Researchers frequently compare this stack with other growth-hormone-axis compounds, including Tesamorelin and Sermorelin, to evaluate:
Consistent handling procedures support research reproducibility:
CJC-1295 (No DAC) and Ipamorelin are supplied for laboratory research applications and educational research purposes only.
No. Research materials supplied by Priority Aminos are not intended for human or veterinary use.
Lot coding supports traceability, documentation, and internal quality procedures.
Comparative analysis may help researchers evaluate differences in receptor selectivity, signaling activity, and research-model design.
Consistent storage procedures help maintain documentation standards and improve research consistency.
Research Use Only (RUO). Not for human or veterinary use.
Join our research newsletter for early access to new compounds and COA updates. We'll send a one-time 10% discount code to your inbox.
Research use only (RUO). No spam โ unsubscribe anytime.